QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NYSE:GMED

Globus Medical (GMED) Stock Forecast, Price & News

$50.27
+0.31 (+0.62%)
(As of 09/28/2023 ET)
Compare
Today's Range
$49.91
$50.74
50-Day Range
$49.10
$62.31
52-Week Range
$48.86
$80.04
Volume
871,484 shs
Average Volume
1.46 million shs
Market Capitalization
$5.05 billion
P/E Ratio
25.01
Dividend Yield
N/A
Price Target
$68.22

Globus Medical MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
35.7% Upside
$68.22 Price Target
Short Interest
Healthy
4.29% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.93
Upright™ Environmental Score
News Sentiment
0.96mentions of Globus Medical in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.82%
From $2.31 to $2.56 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.06 out of 5 stars

Medical Sector

25th out of 969 stocks

Surgical & Medical Instruments Industry

5th out of 100 stocks


GMED stock logo

About Globus Medical (NYSE:GMED) Stock

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED Price History

GMED Stock News Headlines

Globus Medical, Inc. (NYSE:GMED) Sees Large Decline in Short Interest
The Bio-Tech Stock That Needs Your Attention!
There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!
Stifel Upgrades Globus Medical Inc - (GMED)
Globus Medical (NYSE:GMED) Lifted to Buy at Stifel Nicolaus
The Bio-Tech Stock That Needs Your Attention!
There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!
Globus Medical: Almost Having My Back
The Latest Analyst Ratings for Globus Medical
Done deal: Globus Medical, NuVasive complete $3B merger
Piper Sandler Keeps Their Hold Rating on Globus Medical (GMED)
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
See More Headlines
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Company Calendar

Last Earnings
8/03/2023
Today
9/28/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
37957720
Employees
2,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$68.22
High Stock Price Forecast
$78.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+35.9%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
12 Analysts

Profitability

Net Income
$190.17 million
Pretax Margin
23.83%

Debt

Sales & Book Value

Annual Sales
$759.12 million
Cash Flow
$2.89 per share
Book Value
$18.43 per share

Miscellaneous

Free Float
76,049,000
Market Cap
$5.04 billion
Optionable
Optionable
Beta
1.08
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. David C. Paul (Age 56)
    Co-Founder & Exec. Chairman
    Comp: $1.09M
  • Mr. Daniel T. ScavillaMr. Daniel T. Scavilla (Age 58)
    Pres, CEO & Director
    Comp: $1.37M
  • Mr. Keith W. PfeilMr. Keith W. Pfeil (Age 44)
    Sr. VP & CFO
    Comp: $675.89k
  • Ms. Kelly G. Huller Esq. (Age 51)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $543.24k
  • Mr. Brian J. Kearns (Age 56)
    Sr. VP of Bus. Devel. & Investor Relations













GMED Stock - Frequently Asked Questions

Should I buy or sell Globus Medical stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GMED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMED, but not buy additional shares or sell existing shares.
View GMED analyst ratings
or view top-rated stocks.

What is Globus Medical's stock price forecast for 2023?

12 Wall Street analysts have issued 12-month target prices for Globus Medical's stock. Their GMED share price forecasts range from $58.00 to $78.00. On average, they expect the company's share price to reach $68.22 in the next year. This suggests a possible upside of 35.9% from the stock's current price.
View analysts price targets for GMED
or view top-rated stocks among Wall Street analysts.

How have GMED shares performed in 2023?

Globus Medical's stock was trading at $74.27 at the beginning of the year. Since then, GMED stock has decreased by 32.4% and is now trading at $50.20.
View the best growth stocks for 2023 here
.

Are investors shorting Globus Medical?

Globus Medical saw a drop in short interest during the month of September. As of September 15th, there was short interest totaling 4,310,000 shares, a drop of 59.2% from the August 31st total of 10,570,000 shares. Based on an average trading volume of 1,660,000 shares, the short-interest ratio is currently 2.6 days.
View Globus Medical's Short Interest
.

When is Globus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our GMED earnings forecast
.

How were Globus Medical's earnings last quarter?

Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings results on Thursday, August, 3rd. The medical device company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.60 by $0.03. The medical device company had revenue of $291.62 million for the quarter, compared to the consensus estimate of $279.54 million. Globus Medical had a trailing twelve-month return on equity of 12.13% and a net margin of 18.63%. The company's revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.56 EPS.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $2.30-$2.30 for the period, compared to the consensus EPS estimate of $2.30. The company issued revenue guidance of $1.13 billion-$1.13 billion, compared to the consensus revenue estimate of $1.12 billion.

What is David Demski's approval rating as Globus Medical's CEO?

47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Globus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA).

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

Who are Globus Medical's major shareholders?

Globus Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.33%), State Street Corp (2.36%), William Blair Investment Management LLC (2.27%), JPMorgan Chase & Co. (1.89%), Champlain Investment Partners LLC (1.70%) and Hawk Ridge Capital Management LP (1.68%). Insiders that own company stock include Dan Lemaitre, Daniel T Scavilla, Daniel T Scavilla, David D Davidar, David M Demski, James R Tobin, James R Tobin, Keith W Pfeil, Keith W Pfeil and Kelly Huller.
View institutional ownership trends
.

How do I buy shares of Globus Medical?

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Globus Medical's stock price today?

One share of GMED stock can currently be purchased for approximately $50.20.

How much money does Globus Medical make?

Globus Medical (NYSE:GMED) has a market capitalization of $5.04 billion and generates $759.12 million in revenue each year. The medical device company earns $190.17 million in net income (profit) each year or $2.01 on an earnings per share basis.

How many employees does Globus Medical have?

The company employs 2,600 workers across the globe.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The official website for the company is www.globusmedical.com. The medical device company can be reached via phone at (610) 930-1800, via email at investors@globusmedical.com, or via fax at 610-930-2042.

This page (NYSE:GMED) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -